Hitoshi Maeshima

Executive dysfunction in medicated, remitted state of major depression

Yoshiyuki Nakano, Hajime Baba, Hitoshi Maeshima et al. · Journal of Affective Disorders · 2008 · 106 citations

Medicine, Neuroscience, Psychiatry +16

Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)

Tohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 90 citations

Medicine, Pharmacology, Psychiatry +14

Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression

Emi Satomura, Hajime Baba, Yoshiyuki Nakano et al. · Journal of Affective Disorders · 2011 · 64 citations

Life Sciences, Neuroscience, Psychiatry +17

Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: Class-specific influence by tricyclic antidepressants and newer antidepressants

Akiko Nagane, Hajime Baba, Yoshiyuki Nakano et al. · Psychiatry Research · 2014 · 51 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls

Hirofumi Kurita, Hitoshi Maeshima, Sayaka Kida et al. · Journal of Affective Disorders · 2012 · 47 citations

Medicine, Pharmacology, Psychiatry +16